|Bid||90.00 x 900|
|Ask||92.48 x 1000|
|Day's Range||91.34 - 97.90|
|52 Week Range||25.50 - 99.50|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 13, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||69.75|
Schrödinger today announced a strategic collaboration with Thermo Fisher Scientific.
Schrödinger today announced a significant expansion of its work to discover novel antiviral therapeutics for COVID-19.
Schrödinger announced that members of the management team will participate in the BMO 2020 Prescriptions for Success Healthcare Conference.
Schrödinger today announced it will participate in a fireside chat at the Jefferies 2020 Virtual Healthcare Conference.
It's been a pretty great week for Schrödinger, Inc. (NASDAQ:SDGR) shareholders, with its shares surging 11% to...
Schrödinger (Nasdaq: SDGR) will host a conference call and webcast on May 13, 2020 to discuss first quarter 2020 financial results.
Schrödinger appoints Jeffrey A. Chodakewitz, M.D., and Gary Ginsberg to its Board of Directors.
Schrödinger (Nasdaq: SDGR) today announced an expanded collaboration with AstraZeneca focused on refining a biologics modeling solution.
Schrödinger, Inc. (Nasdaq: SDGR) today announced it has entered into a three-year agreement with Google Cloud.